Timing Pharmaceutical Co (6659.TWO) Stock Price
Timing Pharmaceutical Co Price
Over the last 2 years Timing Pharmaceutical Co grew revenue by 5.2% annually, reaching 1.26 B TWD. Earnings per share have grown at 1.6% per year over the last 2 years. For Timing Pharmaceutical Co, the net margin of 4.5% is broadly stable versus 4.9% a few years ago.
Timing Pharmaceutical Co stock price
Timing Pharmaceutical Co business model & stock analysis
Frequently asked questions about Timing Pharmaceutical Co
Converted at the current exchange rate, the Timing Pharmaceutical Co share trades at 0.58 EUR (20.85 TWD).
The revenue cannot currently be calculated for Timing Pharmaceutical Co.
The profit cannot currently be calculated for Timing Pharmaceutical Co.
The P/E ratio cannot be calculated for Timing Pharmaceutical Co at the moment.
The P/S cannot be calculated for Timing Pharmaceutical Co currently.
The Eulerpool Quality Score for Timing Pharmaceutical Co is 1/10.
The ISIN of Timing Pharmaceutical Co is TW0006659006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Timing Pharmaceutical Co is 6659.TWO. The ticker symbol is used to trade Timing Pharmaceutical Co shares on the stock exchange.
Timing Pharmaceutical Co stock
Timing Pharmaceutical Co Peer Group
All fundamentals and in-depth analysis of Timing Pharmaceutical Co
Our stock analysis for Timing Pharmaceutical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Timing Pharmaceutical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.